免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

巴希爾加內血管導管

K 號:K193071 · 2019-12-17

決定日期2019-12-17
產品代碼QEY
諮詢委員會履歷
決定相當於

器材摘要

Bashir Plus Endovascular Catheter is the device name listed in this FDA 510(k) record. The listed applicant is Thrombolex, Inc.. It received FDA 510(k) clearance on 2019-12-17 under 510(k) number K193071. The device is classified under product code QEY. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the Bashir Plus Endovascular Catheter?

Bashir Plus Endovascular Catheter is a medical device that received FDA 510(k) clearance on 2019-12-17. The listed applicant is Thrombolex, Inc.. The 510(k) number is K193071.

When did Bashir Plus Endovascular Catheter receive FDA 510(k) clearance?

Bashir Plus Endovascular Catheter received FDA 510(k) clearance on 2019-12-17, under 510(k) number K193071.

Who is the listed applicant for Bashir Plus Endovascular Catheter?

The FDA 510(k) record lists Thrombolex, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Bashir Plus Endovascular Catheter?

The FDA product code for Bashir Plus Endovascular Catheter is QEY.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Thrombolex, Inc. 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

相關器械(代碼:QEY)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑